Gudkov AV - Search Results

1

Identification of new drug sensitivity genes using genetic suppressor elements: protein arginine N-methyltransferase mediates cell sensitivity to DNA-damaging agents.

Gros L, Delaporte C, Frey S, Decesse J, de Saint-Vincent BR, Cavarec L, Dubart A, Gudkov AV, Jacquemin-Sablon A. Gros L, et al. Among authors: gudkov av. Cancer Res. 2003 Jan 1;63(1):164-71. Cancer Res. 2003. PMID: 12517794

2

Genetic suppressor elements: new tools for molecular oncology--thirteenth Cornelius P. Rhoads Memorial Award Lecture.

Roninson IB, Gudkov AV, Holzmayer TA, Kirschling DJ, Kazarov AR, Zelnick CR, Mazo IA, Axenovich S, Thimmapaya R. Roninson IB, et al. Among authors: gudkov av. Cancer Res. 1995 Sep 15;55(18):4023-8. Cancer Res. 1995. PMID: 7664275

3

Altered expression of ubiquitous kinesin heavy chain results in resistance to etoposide and hypersensitivity to colchicine: mapping of the domain associated with drug response.

Axenovich SA, Kazarov AR, Boiko AD, Armin G, Roninson IB, Gudkov AV. Axenovich SA, et al. Among authors: gudkov av. Cancer Res. 1998 Aug 1;58(15):3423-8. Cancer Res. 1998. PMID: 9699675

4

Selection of genetic suppressor elements conferring resistance to DNA topoisomerase II inhibitors.

Delaporte C, Gros L, Frey S, Coccard D, Cavarec L, Dubar A, Gudkov A, Jacquemin-Sablon A. Delaporte C, et al. Ann N Y Acad Sci. 1999;886:187-90. doi: 10.1111/j.1749-6632.1999.tb09413.x. Ann N Y Acad Sci. 1999. PMID: 10667216 Review. No abstract available.

5

Cooperation of two mutant p53 alleles contributes to Fas resistance of prostate carcinoma cells.

Gurova KV, Rokhlin OW, Budanov AV, Burdelya LG, Chumakov PM, Cohen MB, Gudkov AV. Gurova KV, et al. Among authors: gudkov av. Cancer Res. 2003 Jun 1;63(11):2905-12. Cancer Res. 2003. PMID: 12782597

6

Inhibition of p53 response in tumor stroma improves efficacy of anticancer treatment by increasing antiangiogenic effects of chemotherapy and radiotherapy in mice.

Burdelya LG, Komarova EA, Hill JE, Browder T, Tararova ND, Mavrakis L, DiCorleto PE, Folkman J, Gudkov AV. Burdelya LG, et al. Among authors: gudkov av. Cancer Res. 2006 Oct 1;66(19):9356-61. doi: 10.1158/0008-5472.CAN-06-1223. Cancer Res. 2006. PMID: 17018587

7

p53 determines multidrug sensitivity of childhood neuroblastoma.

Xue C, Haber M, Flemming C, Marshall GM, Lock RB, MacKenzie KL, Gurova KV, Norris MD, Gudkov AV. Xue C, et al. Among authors: gudkov av. Cancer Res. 2007 Nov 1;67(21):10351-60. doi: 10.1158/0008-5472.CAN-06-4345. Cancer Res. 2007. PMID: 17974978

8

Involvement of MDR1 P-glycoprotein in multifactorial resistance to methotrexate.

Norris MD, De Graaf D, Haber M, Kavallaris M, Madafiglio J, Gilbert J, Kwan E, Stewart BW, Mechetner EB, Gudkov AV, Roninson IB. Norris MD, et al. Among authors: gudkov av. Int J Cancer. 1996 Mar 1;65(5):613-9. doi: 10.1002/(SICI)1097-0215(19960301)65:5<613::AID-IJC10>3.0.CO;2-8. Int J Cancer. 1996. PMID: 8598312 Free article.

9

Use of genetic suppressor elements to dissect distinct biological effects of separate p53 domains.

Ossovskaya VS, Mazo IA, Chernov MV, Chernova OB, Strezoska Z, Kondratov R, Stark GR, Chumakov PM, Gudkov AV. Ossovskaya VS, et al. Among authors: gudkov av. Proc Natl Acad Sci U S A. 1996 Sep 17;93(19):10309-14. doi: 10.1073/pnas.93.19.10309. Proc Natl Acad Sci U S A. 1996. PMID: 8816796 Free PMC article.

10

Dominant nature of the resistance to Fas- and tumor necrosis factor-alpha-mediated apoptosis in human prostatic carcinoma cell lines.

Rokhlin OW, Hostager BS, Bishop GA, Sidorenko SP, Glover RA, Gudkov AV, Cohen MB. Rokhlin OW, et al. Among authors: gudkov av. Cancer Res. 1997 Sep 15;57(18):3941-3. Cancer Res. 1997. PMID: 9307276

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

273 results

Search Page